JP2005089467A - 局所塗布による全身吸収性のオキシブチニン塩酸塩ゲル製剤 - Google Patents

局所塗布による全身吸収性のオキシブチニン塩酸塩ゲル製剤 Download PDF

Info

Publication number
JP2005089467A
JP2005089467A JP2004269664A JP2004269664A JP2005089467A JP 2005089467 A JP2005089467 A JP 2005089467A JP 2004269664 A JP2004269664 A JP 2004269664A JP 2004269664 A JP2004269664 A JP 2004269664A JP 2005089467 A JP2005089467 A JP 2005089467A
Authority
JP
Japan
Prior art keywords
gel
oxybutynin
preparation according
gel preparation
oxybutynin hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004269664A
Other languages
English (en)
Japanese (ja)
Inventor
Chin-Chih Chiang
欽治 姜
Koki Do
浩輝 童
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORIENT EUROPHARMA CO Ltd
Original Assignee
ORIENT EUROPHARMA CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ORIENT EUROPHARMA CO Ltd filed Critical ORIENT EUROPHARMA CO Ltd
Publication of JP2005089467A publication Critical patent/JP2005089467A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2004269664A 2003-09-18 2004-09-16 局所塗布による全身吸収性のオキシブチニン塩酸塩ゲル製剤 Pending JP2005089467A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW092125778A TW200512013A (en) 2003-09-18 2003-09-18 Gel formulation of oxybutynin hydrochloride

Publications (1)

Publication Number Publication Date
JP2005089467A true JP2005089467A (ja) 2005-04-07

Family

ID=34311540

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004269664A Pending JP2005089467A (ja) 2003-09-18 2004-09-16 局所塗布による全身吸収性のオキシブチニン塩酸塩ゲル製剤

Country Status (4)

Country Link
US (1) US20050064037A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2005089467A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW200512013A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2005032441A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012526124A (ja) * 2009-05-05 2012-10-25 ワトソン ラボラトリーズ、インコーポレイテッド 過活動膀胱の治療方法および局所オキシブチニン組成物の貯蔵と投与のための装置

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951186A4 (en) 2005-10-19 2009-11-04 Menni Menashe Zinger METHODS FOR TREATING HYPERHIDROSIS
WO2009150408A2 (en) * 2008-06-13 2009-12-17 Summit Corporation Plc Topical antimuscarinic formulations
CN101564377A (zh) * 2009-04-24 2009-10-28 杭州锐思医药科技有限公司 奥昔布宁透皮凝胶及其制备方法
WO2016112263A1 (en) 2015-01-09 2016-07-14 Chase Pharmaceuticals Corporation Oxybutynin transdermal therapeutic system combination

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0698393T3 (da) * 1993-05-19 2002-08-05 Hisamitsu Pharmaceutical Co 3-/-menthoxypropan-1,2-diol som solubiliseringsmiddel og præparat til udvortes brug, der indeholder samme
ATE314092T1 (de) * 1997-09-26 2006-01-15 Noven Pharma Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
DE19812413C1 (de) * 1998-03-20 1999-06-10 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体
US6562368B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US20030124177A1 (en) * 2000-04-26 2003-07-03 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012526124A (ja) * 2009-05-05 2012-10-25 ワトソン ラボラトリーズ、インコーポレイテッド 過活動膀胱の治療方法および局所オキシブチニン組成物の貯蔵と投与のための装置
US8920392B2 (en) 2009-05-05 2014-12-30 Watson Laboratories, Inc. Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
US9259388B2 (en) 2009-05-05 2016-02-16 Watson Pharmaceuticals, Inc. Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
US10449173B2 (en) 2009-05-05 2019-10-22 Allergan Sales, Llc Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions

Also Published As

Publication number Publication date
WO2005032441A1 (en) 2005-04-14
TW200512013A (en) 2005-04-01
US20050064037A1 (en) 2005-03-24
TWI308873B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2009-04-21

Similar Documents

Publication Publication Date Title
US8980290B2 (en) Transdermal compositions for anticholinergic agents
US8609722B2 (en) Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
KR100614361B1 (ko) 남성 발기부전증을 치료하기 위한 프로스타글란딘 조성물및 방법
JP4901042B2 (ja) クロニジン製剤
US10179159B2 (en) Topical anesthetic formulation
US20030139384A1 (en) Method for treating erectile dysfunction and increasing libido in men
US7425340B2 (en) Permeation enhancing compositions for anticholinergic agents
US20130116271A1 (en) Tacrolimus-containing oil-in-water type creamy composition
CN104797252B (zh) 减轻噪音厌恶的兽医方法
US20140037713A1 (en) Transdermal compositions for anti-cholinergic agents
JPWO2009037813A1 (ja) 経皮吸収製剤
US20080138391A1 (en) Skin-friendly drug complexes for transdermal administration
HUP0401816A2 (hu) Prosztaglandin-készítmények és alkalmazásuk erekciós zavarok kezelésére szolgáló gyógyszerek előállítására
US9012480B2 (en) Topical therapy for migraine
CA2489188C (en) Transdermal absorption preparation
US20240382502A1 (en) Compositions and methods for deep dermal drug delivery
CN117482078A (zh) 双醋瑞因或大黄酸局部用制剂及其用途
WO2009150408A2 (en) Topical antimuscarinic formulations
JP3091285B2 (ja) 外用消炎鎮痛剤
JP2005089467A (ja) 局所塗布による全身吸収性のオキシブチニン塩酸塩ゲル製剤
EP0416804A1 (en) External preparation containing amusulosin
US20160310508A1 (en) Testosterone gel compositions and related methods
KR20240134863A (ko) 심부 진피 약물 전달을 위한 스피로노락톤의 약학 조성물
EP1711146A1 (en) Transdermal delivery of oxybutynin in gel formulations
US20060216350A1 (en) Ganglionic blocking agents for the treatment of epithelial diseases

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080520

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081224